The GB virus C (GBV-C) NS3 serine protease inhibits HIV-1 replication in a CD4+ T lymphocyte cell line without decreasing HIV receptor expression.

by Sarah L George, Dino Varmaz, John E Tavis, Adnan Chowdhury
Published 2012-01-01

A Functional Interplay between Human Immunodeficiency Virus Type 1 Protease Residues 77 and 93 Involved in Differential Regulation of Precursor Autoprocessing and Mature Protease A...

by Christopher J Counts, P Shing Ho, Maureen J Donlin, John E Tavis, Chaoping Chen
Published 2015-01-01

Recent Advances in Hepatitis B Treatment

by Georgia-Myrto Prifti, Dimitrios Moianos, Erofili Giannakopoulou, Vasiliki Pardali, John E. Tavis, Grigoris Zoidis
Published 2021-05-01

A novel unsupervised method to identify genes important in the anti-viral response: application to interferon/ribavirin in hepatitis C patients.

by Leonid I Brodsky, Abdus S Wahed, Jia Li, John E Tavis, Takuma Tsukahara, Milton W Taylor
Published 2007-07-01

Establishment of a Replicon Reporter of the Emerging Tick-Borne Bourbon Virus and Use It for Evaluation of Antivirals

by Siyuan Hao, Kang Ning, Xiaomei Wang, Jianke Wang, Fang Cheng, Safder S. Ganaie, John E. Tavis, Jianming Qiu
Published 2020-09-01

Hepatitis C virus diversity and evolution in the full open-reading frame during antiviral therapy.

by Nathan A Cannon, Maureen J Donlin, Xiaofeng Fan, Rajeev Aurora, John E Tavis, Virahep-C Study Group
Published 2008-05-01

Association of Hepatitis B Virus Covalently Closed Circular DNA and Human APOBEC3B in Hepatitis B Virus-Related Hepatocellular Carcinoma.

by Xuan Luo, Yao Huang, Yanmeng Chen, Zeng Tu, Jieli Hu, John E Tavis, Ailong Huang, Yuan Hu
Published 2016-01-01

Role of HVR1 sequence similarity in the cross-genotypic neutralization of HCV

by Alexander I. Mosa, Mounir G. AbouHaidar, Richard A. Urbanowicz, John E. Tavis, Jonathan K. Ball, Jordan J. Feld
Published 2020-09-01

HCV genome-wide genetic analyses in context of disease progression and hepatocellular carcinoma.

by Maureen J Donlin, Elena Lomonosova, Alexi Kiss, Xiaohong Cheng, Feng Cao, Teresa M Curto, Adrian Di Bisceglie, John E Tavis
Published 2014-01-01

Differential in vitro effects of intravenous versus oral formulations of silibinin on the HCV life cycle and inflammation.

by Jessica Wagoner, Chihiro Morishima, Tyler N Graf, Nicholas H Oberlies, Elodie Teissier, Eve-Isabelle Pécheur, John E Tavis, Stephen J Polyak
Published 2011-01-01

Synthesis and Evaluation of Troponoids as a New Class of Antibiotics

by Feng Cao, Cari Orth, Maureen J. Donlin, Patrick Adegboyega, Marvin J. Meyers, Ryan P. Murelli, Mohamed Elagawany, Bahaa Elgendy, John E. Tavis
Published 2018-11-01

Contribution of genome-wide HCV genetic differences to outcome of interferon-based therapy in Caucasian American and African American patients.

by Maureen J Donlin, Nathan A Cannon, Rajeev Aurora, Jia Li, Abdus S Wahed, Adrian M Di Bisceglie, John E Tavis, Virahep-C Study Group
Published 2010-02-01

The hepatitis B virus ribonuclease H is sensitive to inhibitors of the human immunodeficiency virus ribonuclease H and integrase enzymes.

by John E Tavis, Xiaohong Cheng, Yuan Hu, Michael Totten, Feng Cao, Eleftherios Michailidis, Rajeev Aurora, Marvin J Meyers, E Jon Jacobsen, Michael A Parniak, Stefan G Sarafianos
Published 2013-01-01

Diversity of the hepatitis C virus NS5B gene during HIV co-infection.

by Tshegofatso Ngwaga, Ling Kong, Derrick Lin, Cassandra Schoborg, Lynn E Taylor, Kenneth H Mayer, Robert S Klein, David D Celentano, Jack D Sobel, Denise J Jamieson, Caroline C King, John E Tavis, Jason T Blackard
Published 2020-01-01

Synthetic Derivatives of Ciclopirox are Effective Inhibitors of Cryptococcus neoformans

by Jeffrey Lin, Maryam Zangi, Tanguturi Venkata Narayana Hajay Kumar, Makala Shakar Reddy, Lingala Vijaya Raghava Reddy, Subir Kumar Sadhukhan, Daniel P. Bradley, Brenda Moreira-Walsh, Tiffany C. Edwards, Austin T. O’Dea, John E. Tavis, Marvin J. Meyers, Maureen J. Donlin
Published 2021-03-01